Logo
x

Search

Subscribe Now

autoimmune diseases

Merck Entered into a WW Research Collaboration and License Agreement with Synthekine to Develop Novel Cytokine Therapeutics

Merck Entered into a WW Research Collaboration and License Agreement with Synthekine to Develop Novel Cytokine Therapeutics

  • November 2, 2021
Alvotech's AVT02 (a proposed biosimilar to Humira) Receives CHMP's Positive Opinion for the Treatment of Autoimmune Diseases

Alvotech's AVT02 (a proposed biosimilar to Humira) Receives CHMP's Positive Opinion for the Treatment of Autoimmune Diseases

  • September 17, 2021
Merck to Acquire Pandion for ~$1.85B

Merck to Acquire Pandion for ~$1.85B

  • February 26, 2021
Alvotech and DKSH Extend their Collaboration to Commercialize Six Biosimilars in Asia

Alvotech and DKSH Extend their Collaboration to Commercialize Six Biosimilars in Asia

  • September 22, 2020
Innovent's Sulinno (biosimilar- adalimumab) Receives NMPA's Approval for Autoimmune Diseases

Innovent's Sulinno (biosimilar- adalimumab) Receives NMPA's Approval for Autoimmune Diseases

  • September 4, 2020
Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

  • August 21, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.